Yu Miyama

408 total citations
29 papers, 290 citations indexed

About

Yu Miyama is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yu Miyama has authored 29 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 13 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yu Miyama's work include Bladder and Urothelial Cancer Treatments (12 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Urinary and Genital Oncology Studies (10 papers). Yu Miyama is often cited by papers focused on Bladder and Urothelial Cancer Treatments (12 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Urinary and Genital Oncology Studies (10 papers). Yu Miyama collaborates with scholars based in Japan. Yu Miyama's co-authors include Teppei Morikawa, Jimpei Miyakawa, Haruki Kume, Mako Kamiya, Naoko Inoshita, Yasuteru Urano, Ryosuke Kojima, Kyoko Yamamoto, Daisuke Yamada and Masanori Yasuda and has published in prestigious journals such as Journal of the American Chemical Society, SHILAP Revista de lepidopterología and Annals of Surgical Oncology.

In The Last Decade

Yu Miyama

26 papers receiving 287 citations

Peers

Countries citing papers authored by Yu Miyama

Since Specialization

Citations

This map shows the geographic impact of Yu Miyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Miyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Miyama more than expected).

Fields of papers citing papers by Yu Miyama

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Miyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Miyama. The network helps show where Yu Miyama may publish in the future.

Co-authorship network of co-authors of Yu Miyama

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Miyama. A scholar is included among the top collaborators of Yu Miyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Miyama. Yu Miyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Case of Avelumab-Resistant Upper Urothelial Carcinoma Responding to Pembrolizumab 2025 ·Cureus ·(unknown), Suguru Shirotake, Yu Miyama, Takayuki Takahashi, (unknown), Masayuki Hagiwara, (unknown), Masafumi Oyama	0
2	Histological classification of uterine cervical adenocarcinomas: Its alteration and current status 2025 ·Journal of obstetrics and gynaecology research ·Masanori Yasuda, (unknown), Yu Miyama, (unknown), Mitsutake Yano, Akira Yabuno	0
3	Robot-Assisted Partial Cystectomy Using the “Double Bipolar Method” 2024 ·Cureus ·(unknown), (unknown), Akira Yabuno, Yu Miyama, (unknown), Masayuki Hagiwara, Suguru Shirotake, Masanori Yasuda, Masafumi Oyama	2
4	Cervical lymphoepithelioma-like carcinoma with deficient mismatch repair and loss of SMARCA4/BRG1: a case report and five related cases 2024 ·Diagnostic Pathology ·Yu Miyama, Tomomi Kato, Masayasu Satō, Akira Yabuno, Kosei Hasegawa, Masanori Yasuda	0
5	Concordance Between Biopsy and Resection Diagnoses of Uterine Cervical Adenocarcinoma According to the Updated World Health Organization 2020 Classification: A Multi-Institutional Study Elucidating Real-World Practice in Japan 2024 ·Archives of Pathology & Laboratory Medicine ·Fumi Kawakami, Hiroyuki Yanai, Norihiro Teramoto, Yu Miyama, Masanori Yasuda, Sachiko Minamiguchi, M. Iwamoto, Takako Kiyokawa, Yoshiki Mikami	1
6	Choroidal Metastasis From Papillary Renal Cell Carcinomas: A Case Report and a Review of the Literature 2024 ·Cureus ·(unknown), (unknown), Yu Miyama, (unknown), (unknown), Masayuki Hagiwara, Suguru Shirotake, Kent Kanao, Masanori Yasuda, Masafumi Oyama	2
7	Complete response to pembrolizumab in a patient with recurrent and metastatic urothelial bladder carcinoma reflecting coexisting sarcomatoid subtype and glandular differentiation: a case report 2022 ·International Cancer Conference Journal ·Yu Miyama, Kent Kanao, (unknown), Masataka Hirasaki, Masanori Yasuda	3
8	Impact of Cytoreductive Nephrectomy Following Nivolumab Plus Ipilimumab Therapy for Patients With Advanced Renal Cell Carcinoma 2022 ·Anticancer Research ·Suguru Shirotake, Yu Miyama, Yasutaka Baba, Hiroyuki Tajima, Yoshitaka Okada, (unknown), (unknown), Masanori Yasuda, (unknown), (unknown), (unknown), Masafumi Oyama, Koshiro Nishimoto	21
9	Case Study: A Japanese patient with metastatic renal cell carcinoma who achieved long‐term treatment‐free survival with pembrolizumab and axitinib in the KEYNOTE‐426 phase III trial of pembrolizumab and axitinib versus sunitinib 2022 ·IJU Case Reports ·Koshiro Nishimoto, Suguru Shirotake, Yu Miyama, (unknown), Kent Kanao, (unknown), Takayuki Takahashi, (unknown), Masanori Yasuda, Masafumi Oyama	1
10	An autopsy case of prostatic rhabdomyosarcoma with DICER1 hotspot mutation 2020 ·Pathology International ·Yu Miyama, Naohiro Makise, Jimpei Miyakawa, Haruki Kume, Masashi Fukayama, Tetsuo Ushiku	2
11	B7-H3 expression in upper tract urothelial carcinoma associates with adverse clinicopathological features and poor survival 2020 ·Pathology - Research and Practice ·(unknown), Teppei Morikawa, Yu Miyama, Jimpei Miyakawa, Taketo Kawai, Haruki Kume, Motoji Sawabe, Tetsuo Ushiku	8
12	Hepatoid adenocarcinoma of the lung mimicking metastatic hepatocellular carcinoma 2020 ·Autopsy and Case Reports ·Yu Miyama, Takeshi Fujii, (unknown), Hisashi Takaya, Fukuo Kondo	6
13	Inverted papilloma of the urinary bladder shows fluorescence on photodynamic diagnosis using 5-aminolevulinic acid 2020 ·Photodiagnosis and Photodynamic Therapy ·(unknown), Taketo Kawai, Yusuke Sato, Jimpei Miyakawa, Yu Miyama, (unknown), Yoshiyuki Akiyama, Yuta Yamada, Masaki Nakamura, Daisuke Yamada, Motofumi Suzuki, Tetsuo Ushiku, Haruki Kume	2
14	Intracytoplasmic dot‐like inclusions as cytopathologically useful findings of ependymoma: Case report of adolescent supratentorial anaplastic ependymoma with clear cell morphology 2020 ·SHILAP Revista de lepidopterología ·Taku Homma, (unknown), Yu Miyama, Tomonari Suzuki, (unknown), Jun‐ichi Adachi, Masanori Yasuda	1
15	A case of Birt-Hogg-Dubé syndrome implying reduced or no wild-type folliculin without mutated protein is pathogenic 2019 ·European Journal of Medical Genetics ·Yutaka Enomoto, Yukiko Namba, (unknown), (unknown), Keiko Mitani, Haruki Kume, Etsuko Kobayashi, Yu Miyama, Yukio Homma, Tetsuo Ushiku, Kuniaki Seyama	3
16	The loss of BAP1 protein expression predicts poor prognosis in patients with nonmetastatic clear cell renal cell carcinoma with inferior vena cava tumor thrombosis 2018 ·Urologic Oncology Seminars and Original Investigations ·(unknown), Naoko Inoshita, Yuji Miura, Ryosuke Oki, Yu Miyama, (unknown), Kohei Ogawa, Kazushige Sakaguchi, Chihiro Kondoh, Kazuhiro Kurosawa, Shinji Urakami, Toshimi Takano, Toshikazu Okaneya	7
17	Diagnostic utility of Ki-67 immunohistochemistry in small endoscopic biopsies of the ureter and renal pelvis 2017 ·Pathology - Research and Practice ·(unknown), Teppei Morikawa, Jimpei Miyakawa, Yu Miyama, Tohru Nakagawa, Yukio Homma, Masashi Fukayama	3
18	Loss of Stromal Antigen 2 (STAG2) Expression in Upper Urinary Tract Carcinoma: Differential Prognostic Effect According to the Ki-67 Proliferating Index 2017 ·Annals of Surgical Oncology ·Jimpei Miyakawa, Teppei Morikawa, Yu Miyama, Tohru Nakagawa, Taketo Kawai, Yukio Homma, Masashi Fukayama	2
19	Prognostic value of programmed death‐ligand 1 expression in patients with stage III colorectal cancer 2017 ·Cancer Science ·(unknown), Naoko Inoshita, Yuji Miura, Yu Miyama, (unknown), Yukinori Ozaki, Kenji Tomizawa, Yutaka Hanaoka, Shigeo Toda, Koichi Suyama, Yuko Tanabe, (unknown), Takeshi Fujii, Shuichiro Matoba, Hiroya Kuroyanagi, Toshimi Takano	42
20	Lipid Cell and Micropapillary Variants of Urothelial Carcinoma of the Ureter 2015 ·Case Reports in Oncology ·Yu Miyama, Teppei Morikawa, Tohru Nakagawa, Yukio Homma, Masashi Fukayama	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact